Logo-jrhs
J Res Health Sci. 2022;22(3): e00553. doi: 10.34172/jrhs.2022.88
PMID: 36511371        PMCID: PMC10422148

Original Article

The Prevalence of Human Papillomavirus Genotypes in Tehran, Iran

Zahra Shalchimanesh, Maryam Ghane * , Ebrahim Kalantar

Cited by CrossRef: 1

1- Dong S, Zhang Y, Wang Y. Role of extracellular vesicle in human papillomavirus-associated cervical cancer. J Cancer Res Clin Oncol. 2023;149(17):16203 [Crossref]
2- Letafati A, Motlaghzadeh S, Ardekani O, Memarpour B, Seyedi S, Bahari M, Farahani A, Khoshravan A, Sarrafzadeh S, Vasmehjani A, Pournaseri M, Bahrami Y, Talebi F. Uncommon high distribution of HPV-16, HPV-54, and HPV-56 in female referred to a laboratory in Karaj, Iran: indications of a paradigm shift in HPV genotypes?. Virol J. 2024;21(1) [Crossref]
3- Gholamzad A, Khakpour N, Hashemi M, Gholamzad M. Prevalence of high and low risk HPV genotypes among vaccinated and non-vaccinated people in Tehran. Virol J. 2024;21(1) [Crossref]
4- Letafati A, Noroozi M, Fallah T, Farahani A, Nasiri M, Pourmoein H, Sadeghi Z, Ardekani O, Heshmatipour K, Nodeh S, Alipour M, Sadeghipoor S, Azhar I, Parsania M. Distribution of HPV genotypes in Mashhad, Iran: insights from a 2022–2023 study. Virol J. 2024;21(1) [Crossref]
5- Haddadi M, Atefmehr L, Motlaghzadeh S, Hejami F, Elyasi F, Zafarian N, Taghiabadi Z, Aboofazeli A, Yarahmady H, Modaresi P, Dadgar A, Arbabinia M, Naderisemiromi M, Najafpour S, Sharifi A, Gholami A, Mamandi A, Letafati A. Prevailing of HPV-16 and 52 genotype in 2022–2023 in Sanandaj, Iran. Virol J. 2024;21(1) [Crossref]
6- Kalani M, Mirzaei F, Keyghobadi H, Keighobadi G, Raoofat A, Kalani M, Moravej A. Comparing the distribution of common human papillomavirus genotypes among the population of Fars province in southwest Iran with the genotypes included in the available HPV vaccines. Mol Biol Rep. 2024;51(1) [Crossref]